Carolina Munoz-Grajales
Overview
Explore the profile of Carolina Munoz-Grajales including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
38
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Munoz-Grajales C, Barraclough M, Diaz-Martinez J, Su J, Bingham K, Kakvan M, et al.
Front Immunol
. 2024 Feb;
14:1326751.
PMID: 38332909
Objective: Cognitive impairment (CI) is one of the most common manifestations of Neuropsychiatric Systemic Lupus Erythematosus (NPSLE). Despite its frequency, we have a limited understanding of the underlying immune mechanisms,...
2.
Manion K, Munoz-Grajales C, Kim M, Atenafu E, Faheem Z, Gladman D, et al.
Arthritis Rheumatol
. 2023 Dec;
76(5):726-738.
PMID: 38073017
Objective: The aim of this study was to determine the immunologic profile associated with disease flares in patients with systemic lupus erythematosus (SLE) and to investigate the clinical significance of...
3.
Munoz-Grajales C, Yilmaz E, Svenungsson E, Touma Z
Best Pract Res Clin Rheumatol
. 2023 Nov;
37(4):101893.
PMID: 37993371
The young age of onset and chronic/relapsing nature of systemic lupus erythematosus (SLE) make SLE patients prone to develop and accrue organ damage as a result of long-standing disease activity...
4.
Ferri D, Nassar C, Manion K, Kim M, Baglaenko Y, Munoz-Grajales C, et al.
Arthritis Rheumatol
. 2023 Feb;
75(9):1542-1555.
PMID: 36807718
Objective: Elevated levels of serum interferon-α (IFNα) and the disruption of B cell tolerance are central to systemic lupus erythematosus (SLE) immunopathogenesis; however, the relationship between these 2 processes remains...
5.
Kim S, Munoz-Grajales C, Dunn S, Schneider R, Johnson S, Touma Z, et al.
Arthritis Res Ther
. 2023 Feb;
25(1):21.
PMID: 36765391
Background: Elevated levels of interferons (IFNs) are a characteristic feature of systemic autoimmune rheumatic diseases (SARDs) and may be useful in predicting impending symptomatic progression in anti-nuclear antibody-positive (ANA) individuals...
6.
Gupta R, Vanlieshout E, Manion K, Bonilla D, Kim M, Munoz-Grajales C, et al.
Front Immunol
. 2022 Jul;
13:886442.
PMID: 35844549
Systemic Autoimmune Rheumatic Diseases (SARDs) are characterized by the production of anti-nuclear antibodies (ANAs). ANAs are also seen in healthy individuals and can be detected years before disease onset in...
7.
Munoz-Grajales C, Prokopec S, Johnson S, Touma Z, Ahmad Z, Bonilla D, et al.
Rheumatology (Oxford)
. 2021 Jun;
61(3):1092-1105.
PMID: 34175923
Objective: We investigated the autoantibody (autoAb) profiles in ANA+ individuals lacking systemic autoimmune rheumatic disease (SARD) and early SARD patients to determine the key differences between these groups and identify...
8.
Restrepo-Correa R, Rodriguez-Padilla L, Zapata-Castellanos A, Ocampo A, Garcia J, Munoz-Grajales C, et al.
Int J Rheum Dis
. 2017 Nov;
21(11):1946-1954.
PMID: 29152874
Aim: To determine the correlation and concordance between different clinimetric scores in patients with rheumatoid arthritis in two high-complexity reference centers in northwestern Colombia. Method: A cross-sectional study in adults...
9.
Munoz-Grajales C, Chavarriaga J, Marquez J, Pinto L
Reumatol Clin (Engl Ed)
. 2017 Aug;
15(5):e21-e23.
PMID: 28822626
Although antineutrophil cytoplasmic antibody (ANCA) vasculitis has a variety of clinical manifestations, valvular compromise is not common, especially in anti-myeloperoxidase (anti-MPO) antibody (perinuclear [P]-ANCA) vasculitis. We report the case of...
10.
Munoz-Grajales C, Pineda J
Autoimmune Dis
. 2015 Aug;
2015:286783.
PMID: 26236499
The development of autoimmune disorders requires a combination of genetic, immunological, and environmental factors. Infectious agents, such as viruses and bacteria, can trigger autoimmunity through different mechanisms, and for systemic...